BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 222 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $204 | -2.9% | 40 | +14.3% | 0.00% | – |
| Q4 2023 | $210 | -56.4% | 35 | -48.5% | 0.00% | – |
| Q3 2023 | $482 | +28.9% | 68 | +28.3% | 0.00% | – |
| Q2 2023 | $374 | +86.1% | 53 | +120.8% | 0.00% | – |
| Q1 2023 | $201 | -69.8% | 24 | -58.6% | 0.00% | – |
| Q4 2022 | $666 | -33.4% | 58 | -4.9% | 0.00% | – |
| Q3 2022 | $1,000 | – | 61 | +110.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 29 | -32.6% | 0.00% | – |
| Q1 2022 | $1,000 | – | 43 | +258.3% | 0.00% | – |
| Q4 2021 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |